A product made in Columbus reached a major milestone at the end of 2024. Ensure, a nutritional drink made by Abbott ...

and is promoted as the next stage in child nutrition – all in an attempt to convince parents and caregivers to buy a product toddlers don’t need.” Abbott Laboratories is purposefully ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

A legal research organization focused on public health says Abbott Laboratories' marketing of "toddler milk" products to children age 12 months to 36 months as "natural and healthy" is misleading.

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics units overshadowed strength in medical devices, sending its shares down more ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Investment analysts at William Blair dropped their Q1 2025 earnings estimates for shares of Abbott Laboratories in a report ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...